Read More Healthcare Industry News Caris Life Sciences (NASDAQ: CAI) says final Achieve 1 data strengthens the case for Caris Detect, but can MCED execution close the gap? Caris Life Sciences says final Achieve 1 data strengthens Caris Detect. Read why the MCED opportunity looks bigger, and why execution risk still matters. byPallavi MadhirajuApril 1, 2026